Form D — Mirum Pharmaceuticals, Inc.

0001759425-26-000005 · filed Jan 29, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry: Biotechnology
Exemptions: 06c
Reported offering amount: $68,480,000
Reported amount sold: $68,480,000
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: Mirum Pharmaceuticals, Inc.
CIK: 1759425
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: —
Address: 989 EAST HILLSDALE BOULEVARD, SUITE 300
FOSTER CITY, CA 94404
Phone: 650-667-4085

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Christopher Peetz · Executive Officer

Foster City, CA Find on LinkedIn ↗
Eric Bjerkholt · Executive Officer

Foster City, CA Find on LinkedIn ↗
Peter Radovich · Executive Officer

Foster City, CA Find on LinkedIn ↗
Laura Brege · Director

Foster City, CA Find on LinkedIn ↗
Timothy Walbert · Director

Foster City, CA Find on LinkedIn ↗
William C. Fairey · Director

Foster City, CA Find on LinkedIn ↗
Patrick Heron · Director

Foster City, CA Find on LinkedIn ↗
Lon Cardon · Director

Foster City, CA Find on LinkedIn ↗
Saira Ramasastry · Director

Foster City, CA Find on LinkedIn ↗
Laurent Fischer · Director

Foster City, CA Find on LinkedIn ↗
Michael Grey · Director

Foster City, CA Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗